ArticleInternational journal of clinical oncology2024

MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

Hirotaka Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.